Age-related effects of sodium arsenite on splenocyte proliferation and Th1/Th2 cytokine production

Archives of Pharmacal Research

Volumn 35, Issue 2, 2012, Pages 375-382

  Cho, Yuri ^a   Ahn, Kyong Hoon ^a   Back, Moon Jung ^a   Choi, Jong Min ^a   Ji, Jung Eun ^a   Won, Jong Hoon ^a   Fu, Zhicheng ^a   Jang, Ji Min ^a   Kim, Dae Kyong ^a  

^a Chung Ang University   (South Korea)

Author keywords

Aging; Arsenic; Cytokine; Heavy metal; Immunotoxicity; Splenocyte

Indexed keywords

ARSENITE SODIUM; CD3 ANTIBODY; CONCANAVALIN A; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; ARSENOUS ACID DERIVATIVE; CD3 ANTIGEN; ENZYME INHIBITOR; SODIUM DERIVATIVE;

AGED; AGING; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GROUPS BY AGE; IMMUNE RESPONSE; IMMUNOTOXICITY; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; ANIMAL; CELL CULTURE; DOSE RESPONSE; DRUG EFFECT; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; SPLEEN;

AGING; ANIMALS; ANTIGENS, CD3; ARSENITES; CELL PROLIFERATION; CELLS, CULTURED; CONCANAVALIN A; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; IMMUNE TOLERANCE; MALE; MICE; SODIUM COMPOUNDS; SPLEEN; TH1 CELLS; TH2 CELLS;

EID: 84862655127     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-012-0219-3     Document Type: Article

References (51)

1. Banerjee, N., Nandy, S., Kearns, J. K., Bandyopadhyay, A. K., Das, J. K., Majumder, P., Basu, S., Banerjee, S., Sau, T. J., States, J. C., and Giri, A. K., Polymorphisms in the TNF-alpha and IL10 gene promoters and risk of arsenicinduced skin lesions and other nondermatological health effects. Toxicol. Sci., 121, 132-139 (2011).
2. Burns, L. A. and Munson, A. E., Gallium arsenide selectively inhibits T cell proliferation and alters expression of CD25 (IL-2R/p55). J. Pharmacol. Exp. Ther., 265, 178-186 (1993).
3. Cantrell, D. A. and Smith, K. A., The interleukin-2 T-cell system: a new cell growth model. Science, 224, 1312-1316 (1984).
4. Cheng, H. Y., Li, P., David, M., Smithgall, T. E., Feng, L., and Lieberman, M. W., Arsenic inhibition of the JAKSTAT pathway. Oncogene, 23, 3603-3612 (2004).
5. Concha, G., Vogler, G., Lezcano, D., Nermell, B., and Vahter, M., Exposure to inorganic arsenic metabolites during early human development. Toxicol. Sci., 44, 185-190 (1998).
6. Conde, P., Acosta-Saavedra, L. C., Goytia-Acevedo, R. C., and Calderon-Aranda, E. S., Sodium arsenite-induced inhibition of cell proliferation is related to inhibition of IL-2 mRNA expression in mouse activated T cells. Arch. Toxicol., 81, 251-259 (2007).
7. Das, S., Pan, D., Bera, A. K., Rana, T., Bhattacharya, D., Bandyapadyay, S., De, S., Sreevatsava, V., Bhattacharya, S., Das, S. K., and Bandyopadhayay, S., Sodium arsenite mediated immuno-disruption through alteration of transcription profile of cytokines in chicken splenocytes under in vitro system. Mol. Biol. Rep., 38, 171-176 (2011).
8. Desai, A., Grolleau-Julius, A., and Yung, R., Leukocyte function in the aging immune system. J. Leukoc. Biol., 87, 1001-1009 (2010).
9. Douziech, N., Seres, I., Larbi, A., Szikszay, E., Roy, P. M., Arcand, M., Dupuis, G., and Fulop, T., Jr., Modulation of human lymphocyte proliferative response with aging. Exp. Gerontol., 37, 369-387 (2002).
10. Engwerda, C. R., Fox, B. S., and Handwerger, B. S., Cytokine production by T lymphocytes from young and aged mice. J. Immunol., 156, 3621-3630 (1996).
11. Banerjee, N., Nandy, S., Kearns, J. K., Bandyopadhyay, A. K., Das, J. K., Majumder, P., Basu, S., Banerjee, S., Sau, T. J., States, J. C., and Giri, A. K., Polymorphisms in the TNF-alpha and IL10 gene promoters and risk of arsenicinduced skin lesions and other nondermatological health effects. Toxicol. Sci., 121, 132-139 (2011).
12. Burns, L. A. and Munson, A. E., Gallium arsenide selectively inhibits T cell proliferation and alters expression of CD25 (IL-2R/p55). J. Pharmacol. Exp. Ther., 265, 178-186 (1993).
13. Cantrell, D. A. and Smith, K. A., The interleukin-2 T-cell system: a new cell growth model. Science, 224, 1312-1316 (1984).
14. Cheng, H. Y., Li, P., David, M., Smithgall, T. E., Feng, L., and Lieberman, M. W., Arsenic inhibition of the JAKSTAT pathway. Oncogene, 23, 3603-3612 (2004).
15. Concha, G., Vogler, G., Lezcano, D., Nermell, B., and Vahter, M., Exposure to inorganic arsenic metabolites during early human development. Toxicol. Sci., 44, 185-190 (1998).
16. Conde, P., Acosta-Saavedra, L. C., Goytia-Acevedo, R. C., and Calderon-Aranda, E. S., Sodium arsenite-induced inhibition of cell proliferation is related to inhibition of IL-2 mRNA expression in mouse activated T cells. Arch. Toxicol., 81, 251-259 (2007).
17. Das, S., Pan, D., Bera, A. K., Rana, T., Bhattacharya, D., Bandyapadyay, S., De, S., Sreevatsava, V., Bhattacharya, S., Das, S. K., and Bandyopadhayay, S., Sodium arsenite mediated immuno-disruption through alteration of transcription profile of cytokines in chicken splenocytes under in vitro system. Mol. Biol. Rep., 38, 171-176 (2011).
18. Desai, A., Grolleau-Julius, A., and Yung, R., Leukocyte function in the aging immune system. J. Leukoc. Biol., 87, 1001-1009 (2010).
19. Douziech, N., Seres, I., Larbi, A., Szikszay, E., Roy, P. M., Arcand, M., Dupuis, G., and Fulop, T., Jr., Modulation of human lymphocyte proliferative response with aging. Exp. Gerontol., 37, 369-387 (2002).
20. Engwerda, C. R., Fox, B. S., and Handwerger, B. S., Cytokine production by T lymphocytes from young and aged mice. J. Immunol., 156, 3621-3630 (1996).
21. Ernst, D. N., Weigle, W. O., Mcquitty, D. N., Rothermel, A. L., and Hobbs, M. V., Stimulation of murine T cell subsets with anti-CD3 antibody. Age-related defects in the expression of early activation molecules. J. Immunol., 142, 1413-1421 (1989).
22. Garcia, G. G. and Miller, R. A., Single-cell analyses reveal two defects in peptide-specific activation of naive T cells from aged mice. J. Immunol., 166, 3151-3157 (2001).
23. Gardner, E. M. and Murasko, D. M., Age-related changes in Type 1 and Type 2 cytokine production in humans. Biogerontology, 3, 271-290 (2002).
24. Gonsebatt, M. E., Vega, L., Herrera, L. A., Montero, R., Rojas, E., Cebrian, M. E., and Ostrosky-Wegman, P., Inorganic arsenic effects on human lymphocyte stimulation and proliferation. Mutat. Res., 283, 91-95 (1992).
25. Gruver, A. L., Hudson, L. L., and Sempowski, G. D., Immunosenescence of ageing. J. Pathol., 211, 144-156 (2007).
26. Hallquist, N., Hakki, A., Wecker, L., Friedman, H., and Pross, S., Differential effects of nicotine and aging on splenocyte proliferation and the production of Th1-versus Th2-type cytokines. Proc. Soc. Exp. Biol. Med., 224, 141-146 (2000).
27. Heydorn, K., Environmental variation of arsenic levels in human blood determines by neutron activation analysis. Clin. Chim. Acta, 28, 349-357 (1970).
28. Hirokawa, K., Age-related changes of signal transduction in T cells. Exp. Gerontol., 34, 7-18 (1999).
29. Horvathova, M., Jahnova, E., Szabova, M., Tulinska, M., Kuricova, M., Liskova, A., Volkovova, K., and Dusinska, M., The relationship between cell surface markers, cytokines, ageing, and cigarette smoking. Bratisl. Lek. Listy, 110, 394-400 (2009).
30. Jadhav, S. H., Sarkar, S. N., Ram, G. C., and Tripathi, H. C., Immunosuppressive effect of subchronic exposure to a mixture of eight heavy metals, found as groundwater contaminants in different areas of India, through drinking water in male rats. Arch. Environ. Contam. Toxicol., 53, 450-458 (2007).
31. Kirk, C. J., Freilich, A. M., and Miller, R. A., Age-related decline in activation of JNK by TCR-and CD28-mediated signals in murine T-lymphocytes. Cell Immunol., 197, 75-82 (1999).
32. Li, J. H. and Rossman, T. G., Inhibition of DNA ligase activity by arsenite: a possible mechanism of its comutagenesis. Mol. Toxicol., 2, 1-9 (1989).
33. Mak, N. K., Wong, R. N., Leung, K. N., and Fung, M., Involvement of tumor necrosis factor (TNF-alpha) in arsenic trioxide induced apoptotic cell death of murine myeloid leukemia cells. Toxicol. Lett., 135, 79-87 (2002).
34. Makinodan, T., Studies on the influence of age on immune response to understand the biology of immunosenescence. Exp. Gerontol., 33, 27-38 (1998).
35. Mandal, B. K., Ogra, Y., Anzai, K., and Suzuki, K. T., Speciation of arsenic in biological samples. Toxicol. Appl. Pharmacol., 198, 307-318 (2004).
36. Martin-Chouly, C., Morzadec, C., Bonvalet, M., Galibert, M. D., Fardel, O., and Vernhet, L., Inorganic arsenic alters expression of immune and stress response genes in activated primary human T lymphocytes. Mol. Immunol., 48, 956-965 (2011).
37. Mauderly, J. L., Jones, R. K., Griffith, W. C., Henderson, R. F., and Mcclellan, R. O., Diesel exhaust is a pulmonary carcinogen in rats exposed chronically by inhalation. Fundam. Appl. Toxicol., 9, 208-221 (1987).
38. Maue, A. C., Yager, E. J., Swain, S. L., Woodland, D. L., Blackman, M. A., and Haynes, L., T-cell immunosenescence: lessons learned from mouse models of aging. Trends Immunol., 30, 301-305 (2009).
39. McElhaney, J. E., Xie, D., Hager, W. D., Barry, M. B., Wang, Y., Kleppinger, A., Ewen, C., Kane, K. P., and Bleackley, R. C., T cell responses are better correlates of vaccine protection in the elderly. J. Immunol., 176, 6333-6339 (2006).
40. Miller, R. A., The aging immune system: primer and prospectus. Science, 273, 70-74 (1996).
41. Shearer, G. M., Th1/Th2 changes in aging. Mech. Ageing Dev., 94, 1-5 (1997).
42. Soto-Pena, G. A., Luna, A. L., Acosta-Saavedra, L., Conde, P., Lopez-Carrillo, L., Cebrian, M. E., Bastida, M., Calderon-Aranda, E. S., and Vega, L., Assessment of lymphocyte subpopulations and cytokine secretion in children exposed to arsenic. FASEB J., 20, 779-781 (2006).
43. Soto-Pena, G. A. and Vega, L., Arsenic interferes with the signaling transduction pathway of T cell receptor activation by increasing basal and induced phosphorylation of Lck and Fyn in spleen cells. Toxicol. Appl. Pharmacol., 230, 216-226 (2008).
44. Su, C. and Puls, R. W., Arsenate and arsenite removal by zerovalent iron: kinetics, redox transformation, and implications for in situ groundwater remediation. Environ. Sci. Technol., 35, 1487-1492 (2001).
45. Sunil, V. R., Patel, K. J., Mainelis, G., Turpin, B. J., Ridgely, S., Laumbach, R. J., Kipen, H. M., Nazarenko, Y., Veleeparambil, M., Gow, A. J., Laskin, J. D., and Laskin, D. L., Pulmonary effects of inhaled diesel exhaust in aged mice. Toxicol. Appl. Pharmacol., 241, 283-293 (2009).
46. Vega, L., Montes De Oca, P., Saavedra, R., and Ostrosky-Wegman, P., Helper T cell subpopulations from women are more susceptible to the toxic effect of sodium arsenite in vitro. Toxicology, 199, 121-128 (2004).
47. Verghese, A. and Berk, S. L., Bacterial pneumonia in the elderly. Medicine (Baltimore), 62, 271-285 (1983).
48. Vu, T., Farish, S., Jenkins, M., and Kelly, H., A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine, 20, 1831-1836 (2002).
49. Wu, D. and Meydani, S. N., Age-associated changes in immune and inflammatory responses: impact of vitamin E intervention. J. Leukoc. Biol., 84, 900-914 (2008).
50. Yoshida, T., Shimamura, T., and Shigeta, S., Enhancement of the immune response in vitro by arsenic. Int. J. Immunopharmacol., 9, 411-415 (1987).
51. Yu, H. S., Chang, K. L., Yu, C. L., Wu, C. S., Chen, G. S., and Ho, J. C., Defective IL-2 receptor expression in lymphocytes of patients with arsenic-induced Bowen's disease. Arch. Dermatol. Res., 290, 681-687 (1998).